skip to content

Cambridge Immunology Network

Latest news

Rare genetic variants confer largest increase in type 2 diabetes risk seen to date

7 July 2021

Scientists at the University of Cambridge have identified rare genetic variants – carried by one in 3,000 people – that have a larger impact on the risk of developing type 2 diabetes than any previously identified genetic effect. Read the original article here>

Scientists identify 160 new drugs that could be repurposed against COVID-19

30 June 2021

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19 clinical trials. Read the original article here>

Upgrading PPE for staff working on COVID-19 wards cut hospital-acquired infections dramatically

29 June 2021

When Addenbrooke’s Hospital in Cambridge upgraded its face masks for staff working on COVID-19 wards to filtering face piece 3 (FFP3) respirators, it saw a dramatic fall – up to 100% – in hospital-acquired SARS-CoV-2 infections among these staff. Read the original article here>

Upcoming CIN Webinars

There are no upcoming talks currently scheduled in this series.